Literature DB >> 34657737

Antibacterial and anti-inflammatory effects of Lactobacillus reuteri in its biofilm state contribute to its beneficial effects in a rat model of experimental necrotizing enterocolitis.

Rita D Shelby1, Pamela Mar1, Grace E Janzow1, Lauren Mashburn-Warren2, Natalie Tengberg1, Jason B Navarro2, Jacob M Allen2, Joseph Wickham2, Yijie Wang1, Michael T Bailey2, Steven D Goodman2, Gail E Besner3.   

Abstract

INTRODUCTION: Necrotizing enterocolitis (NEC) remains a significant surgical emergency in neonates. We have demonstrated the efficacy of Lactobacillus reuteri (Lr) in protecting against experimental NEC when administered as a biofilm by incubation with maltose loaded dextranomer microspheres. Lr possesses antimicrobial and anti-inflammatory properties. We developed mutant strains of Lr to examine the importance of its antimicrobial and anti-inflammatory properties in protecting the intestines from NEC.
METHODS: Premature rat pups were exposed to hypoxia/hypothermia/hypertonic feeds to induce NEC. To examine the importance of antimicrobial reuterin and anti-inflammatory histamine, pups received either native or mutant forms of Lr, in either its planktonic or biofilm states, prior to induction of NEC. Intestinal histology was examined upon sacrifice.
RESULTS: Compared to no treatment, administration of a single dose of Lr in its biofilm state significantly decreased the incidence of NEC (67% vs. 18%, p < 0.0001), whereas Lr in its planktonic state had no significant effect. Administration of reuterin-deficient or histamine-deficient forms of Lr, in either planktonic or biofilm states, resulted in significant loss of efficacy.
CONCLUSION: Antimicrobial and anti-inflammatory effects of Lr contribute to its beneficial effects against NEC. This suggests that both infectious and inflammatory components contribute to the etiology of NEC.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anti-inflammatory; Antibacterial; Biofilm; Necrotizing enterocolitis; Probiotics

Mesh:

Substances:

Year:  2021        PMID: 34657737     DOI: 10.1016/j.jpedsurg.2021.09.001

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.549


  3 in total

Review 1.  Next-Generation Probiotic Therapy to Protect the Intestines From Injury.

Authors:  Mecklin V Ragan; Samantha J Wala; Steven D Goodman; Michael T Bailey; Gail E Besner
Journal:  Front Cell Infect Microbiol       Date:  2022-06-28       Impact factor: 6.073

2.  Effects of Probiotics on Gut Microbiomes of Extremely Preterm Infants in the Neonatal Intensive Care Unit: A Prospective Cohort Study.

Authors:  Ching-Min Chang; Ming-Horng Tsai; Wei-Chao Liao; Peng-Hong Yang; Shiao-Wen Li; Shih-Ming Chu; Hsuan-Rong Huang; Ming-Chou Chiang; Jen-Fu Hsu
Journal:  Nutrients       Date:  2022-08-08       Impact factor: 6.706

Review 3.  Biofilm-based delivery approaches and specific enrichment strategies of probiotics in the human gut.

Authors:  Jie Gao; Faizan Ahmed Sadiq; Yixin Zheng; Jinrong Zhao; Guoqing He; Yaxin Sang
Journal:  Gut Microbes       Date:  2022 Jan-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.